Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
INDUSTRY OVERVIEW
SCOPE AND METHODOLOGY
MEXICO IVD MARKET SUMMARY
Figure 1-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)
CHAPTER 2: MEXICO OVERVIEW
POPULATION
Table 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+, Total Population)
Figure 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+)
Figure 2-2: Total Number of Births in Mexico by Year, 1980-2010 and Forecast 2020-2050
Figure 2-3: Mexico Life Expectancy at Birth in Years, 2010-2050
Population Urbanization
ECONOMY AND HEALTH SPENDING
Figure 2-4: Mexico GDP, GDP (PPP) and Health Spending, 1990-2015
Figure 2-5: Mexico Distribution of Income or Consumption by Quintile, 1990-2014 (Income share held by highest 20%, Income share held by fourth 20%, Income share held by third 20%, Income share held by second 20%, Income share held by lowest 20%)
CHAPTER 3: THE HEALTH SYSTEM IN MEXICO
HEALTH INFRASTRUCTURE
Figure 3-1: Health Expenditures, Public vs. Private, as a % of Total Health Expenditures, 2015
Medical Facilities
Figure 3-2: Distribution of JCI Accredited Facilities by Metropolitan Area (Culiacan, Tijuana, Cancun, Chihuahua, Mexico City)
Figure 3-3: Distribution of JCI Accredited Facilities by Type (%; Hospital Program, Ambulatory Care)
Figure 3-4: Distribution of JCI Accredited Facilities by Length of Time from First Accreditation (Withdrawn/Expired, 5+ Years, 2-5 Years, Less Than 2 Years)
Figure 3-5: Hospital Bed Density per 1,000 Population by Country,2016 Estimates (United States, UnitedKingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia) Physicians and Health Professionals
Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (United States, United
Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia)
Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (United States,United Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia)
The Mexican Diagnostic Laboratory Environment
Figure 3-8: Laboratories and Collection Sites in Mexico by Type, 2016 (%; Commercial Laboratories,Collection Sites/Patient Service Centers)
Figure 3-9: Distribution of Volume, Mexico’s Leading Clinical Laboratory Service Providers, 2016 (%) Medical Device Regulation
Table 3-1: Market Drivers and Inhibitors for Entering Mexico’s Medical Device Market Mexico’s Growing Medical Tourism Industry
HEALTH INDICATORS
General Health
Disease Profiles in Mexico
Table 3-2: Top 5 Cancers Affecting Mexican Population (ranked by total number of cases), 2010-2016
Figure 3-10: Medical Conditions/Diseases Prevalence in Mexico (Tuberculosis, Malaria, HIV, Diabetes,Dengue, Cardiovascular Diseases, Cancer)
CHAPTER 4: IVD MARKETS IN MEXICO
MEXICO IVD MARKET SUMMARY
Table 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry,Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other, Total)
Figure 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry,
Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other,
Histology, Other)
Figure 4-2: Mexico In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC GlucosePOC Other, Histology, Other)
CLINICAL CHEMISTRY
Figure 4-3: Mexico – Clinical Chemistry Market, 2016-2021
IMMUNOASSAY
Table 4-2: Mexico – Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
Figure 4-4: Mexico – Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
MICROBIOLOGY/MOLECULAR
Table 4-3: Mexico – Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
Figure 4-5: Mexico Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
POINT-OF-CARE
Table 4-4: Mexico – POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Other, Total POC)
Figure 4-6: Mexico POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Other)
HISTOLOGY
Figure 4-7: Mexico – Histology Market, 2016-2021
CHAPTER 5: COMPETITIVE ANALYSIS AND PROFILES
COMPETITIVE SUMMARY
Table 5-1: Leading IVD Market Suppliers in Mexico, Market Share Percentage, 2016
Figure 5-1: Leading IVD Market Suppliers in Mexico, 2016 (%)
ABBOTT LABORATORIES
Table 5-2: Abbott Laboratories Company Summary
Company Overview
Company Performance
Product Summary
BECTON, DICKINSON AND COMPANY
Table 5-3: Becton, Dickinson and Company Summary
Company Overview
Company Performance
Product Summary
BIOMÉRIEUX S.A.
Table 5-4: bioMerieux Summary
Company Overview
Company Performance
Product Summary
DANAHER
Table 5-5: Danaher Summary
Company Overview
Company Performance
Product Summary
DIASORIN S.P.A.
Table 5-6: DiaSorin S.p.A. Summary
Company Overview
Company Performance
Product Summary
LIFESCAN, INC
Table 5-7: LifeScan Summary
Company Overview
Company Performance
Product Summary
ROCHE (F. HOFFMAN-LA ROCHE, LTD.)
Table 5-8: Roche Group Summary
Company Overview
Company Performance
Product Summary
SIEMENS HEALTHINEERS
Table 5-9: Siemens Healthineers Company Summary
Company Overview
Company Performance
Product Summary
SYSMEX CORPORATION
Table 5-10: Sysmex Corporation Summary
Company Overview
Company Performance
Product Summary
THERMO FISHER SCIENTIFIC
Table 5-11: Thermo Fisher Summary
Company Overview
Company Performance
Product Summary
APPENDIX: SOURCES OF INFORMATION
